E-LIB Suche - Ergebnisse für: Acharyya, Suddhasatta

1

ENESTfreedom 144-Week Update: Long-Term Treatment-Free Remi..:

Radich, Jerald P. ; Masszi, Tamás ; Gómez Casares, María Teresa...
Clinical Lymphoma Myeloma and Leukemia. 18 (2018) - p. S226 , 2018

Link: https://doi.org/10.1016/..

2

Patient‐reported outcomes of multiple myeloma patients trea..:

Richardson, Paul G. ; Schlossman, Robert L. ; Roy, Anuja N....
British Journal of Haematology. 181 (2018) 5 - p. 628-636 , 2018

Link: https://doi.org/10.1111/..

3

Corrigendum to "Surrogacy of progression free survival for ..:

Kundu, Madan G. ; Acharyya, Suddhasatta
Contemporary Clinical Trials. 60 (2017) - p. 126 , 2017

Link: https://doi.org/10.1016/..

4

Surrogacy of progression free survival for overall survival..:

Kundu, Madan G. ; Acharyya, Suddhasatta
Contemporary Clinical Trials. 53 (2017) - p. 20-28 , 2017

Link: https://doi.org/10.1016/..

5

A Phase II Study of Patupilone (EPO906) in Patients With Pl..:

Smit, Willem M. ; Šufliarsky, Jozef ; Werner, Theresa L....
Clinical Ovarian and Other Gynecologic Cancer. 5 (2012) 2 - p. 53-59 , 2012

Link: https://doi.org/10.1016/..

6

Effectiveness of different methods for delivering tailored ..:

Gans, Kim M ; Risica, Patricia M ; Strolla, Leslie O...
International Journal of Behavioral Nutrition and Physical Activity. 6 (2009) 1 - p. 24 , 2009

Link: https://doi.org/10.1186/..

7

Assessing Fat-related Dietary Behaviors among Black Women: ..:

Risica, Patricia Markham ; Burkholder, Gary ; Gans, Kim M....
Journal of Nutrition Education and Behavior. 39 (2007) 4 - p. 197-204 , 2007

Link: https://doi.org/10.1016/..

8

Developmental Trajectories of Cocaine-and-Other-Drug—Expose..:

MAYES, LINDA C. ; CICCHETTI, DOMENIC ; ACHARYYA, SUDDHASATTA.
Journal of Developmental & Behavioral Pediatrics. 24 (2003) 5 - p. 323-335 , 2003

Link: https://doi.org/10.1097/..

9

The spectrum of social phobia in the zurich cohort study of..:

Merikangas, Kathleen Ries ; Avenevoli, Shelli ; Acharyya, Suddhasatta..
Biological Psychiatry. 51 (2002) 1 - p. 81-91 , 2002

Link: https://doi.org/10.1016/..

10

Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung C..:

Li, Bob T ; Smit, Egbert F ; Goto, Yasushi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066448/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung C..:

Li, Bob T ; Smit, Egbert F ; Goto, Yasushi...
qt5mt7z37v. , 2022

Link: https://escholarship.org..

12

Surrogacy of progression free survival for overall survival..:

Kundu, Madan G ; Acharyya, Suddhasatta
http://arxiv.org/abs/1608.04300. , 2016

Link: http://arxiv.org/abs/160..

13

Whole-Body MR Imaging for Staging of Malignant Tumors in Pe..:

Siegel, Marilyn J ; Acharyya, Suddhasatta ; Hoffer, Frederic A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558875. , 2013

Link: http://www.ncbi.nlm.nih...

14

Use of BI-RADS 3–Probably Benign Category in the American C..:

Baum, Janet K ; Hanna, Lucy G ; Acharyya, Suddhasatta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121012. , 2011

Link: http://www.ncbi.nlm.nih...

15

Comparison of Acquisition Parameters and Breast Dose in Dig..:

Hendrick, R. Edward ; Pisano, Etta D ; Averbukh, Alice...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854416. , 2010

Link: http://www.ncbi.nlm.nih...